FindMyKOL
Clinical trialNCT07824583RecruitingInterventional

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

NCT07824583 is an interventional trial sponsored by Varian, a Siemens Healthineers Company. As of 21 Nov 2026, it is recruiting participants. It studies Abdominal Cancer, Liver Cancer, Adult and 3 more conditions. The registry lists an enrollment of 20 participants at 2 sites in 1 country. The registry lists a start date of 31 Jul 2026 and a primary completion date of 28 Feb 2027. One of its registered investigators has a FindMyKOL profile.

SponsorVarian, a Siemens Healthineers CompanyEnrollment20Abdominal CancerLiver Cancer, AdultLung Cancer (Diagnosis)Pancreatic CancerThoracic Cancers
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT07824583
FieldValue
Registry IDNCT07824583
StatusRecruiting
Study typeInterventional trial
Lead sponsorVarian, a Siemens Healthineers Company
Enrollment20
Registered sites2
Countries1
ConditionsAbdominal Cancer, Liver Cancer, Adult, Lung Cancer (Diagnosis), Pancreatic Cancer and Thoracic Cancers
Start31 Jul 2026
Primary completion28 Feb 2027
Study completion31 May 2027
Last update posted17 Sept 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this research is to evaluate the "Next Generation Delivery System" (NGDS) and determine if this machine will be more efficient at delivering radiation in shorter treatment time and better patient tolerance, with less breath holding.

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Missouri, United States1 site, 1 recruiting
  • Siteman Cancer Center Washington University

    St Louis

    Pamela Samson
    Recruiting
Ohio, United States1 site, 1 recruiting
  • University Hospital Cleveland Medical Center

    Cleveland

    Lauren Henke
    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhio: 1 site, 1 recruitingOH1PennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouri: 1 site, 1 recruitingMO1KentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT07824583

Each answer restates registry values shown on this page.

What is NCT07824583?

NCT07824583 is an interventional trial sponsored by Varian, a Siemens Healthineers Company. It studies Abdominal Cancer, Liver Cancer, Adult and 3 more conditions.

Is NCT07824583 recruiting?

As of 21 Nov 2026, it is recruiting participants. 2 of its 2 sites list their own status as recruiting.

Where does NCT07824583 run?

The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.

When is NCT07824583 expected to complete?

The registry lists a primary completion date of 28 Feb 2027 and a study completion date of 31 May 2027. The sponsor last updated the record on 17 Sept 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.